Ignite Creation Date:
2024-05-06 @ 8:21 AM
Last Modification Date:
2024-10-26 @ 11:58 AM
Study NCT ID:
NCT02711202
Status:
COMPLETED
Last Update Posted:
2016-03-17
First Post:
2016-03-09
Brief Title:
Sequential Targeting of Cluster of Differentiation 52 CD52 and Tumor Necrosis Factor TNF Allows Early Minimization Therapy in Kidney Transplantation
Sponsor:
Institute for Clinical and Experimental Medicine
Organization:
Institute for Clinical and Experimental Medicine
Organization Data
Organization:
Institute for Clinical and Experimental Medicine
Class:
OTHER_GOV
Study ID:
EudraCT Number 2006-003110-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institute for Clinical and Experimental Medicine
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Petra Hruba
Responsible Party Title:
IKEM
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Institute for Clinical and Experimental Medicine
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Charite University Berlin Germany | OTHER |
| Miltenyi Biomedicine GmbH | INDUSTRY |